Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide radioligand therapies focused on ...
The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.